Cyclin-dependent kinase 5 activity regulates pain signaling

PNAS, 2006 · DOI: 10.1073/pnas.0510405103 · Published: January 17, 2006

Simple Explanation

The study investigates the role of cyclin-dependent kinase 5 (Cdk5) in pain signaling. Cdk5 is an enzyme involved in nervous system development and disease. The researchers found that Cdk5 and its activator p35 are expressed in neurons that sense pain, and this expression changes during inflammation. Inflammation leads to increased activity of Cdk5. Mice with reduced Cdk5 activity (p35 knockout mice) were less sensitive to painful stimuli, while mice with increased Cdk5 activity were more sensitive. This suggests that Cdk5 activity is important for pain signaling.

Study Duration

Not specified

Participants

Mice and rats

Evidence Level

Level IV; Animal Studies (Knockout and Transgenic Mice), In vitro assays

Key Findings

1
Cdk5 and p35 are expressed in pain-sensing neurons (nociceptors) within the dorsal root ganglia (DRG), trigeminal ganglia (TG), and spinal cord (SC).
2
Peripheral inflammation increases Cdk5 protein levels and activity in DRG and SC.
3
Mice lacking p35 (and thus having reduced Cdk5 activity) exhibit delayed responses to thermal pain, while mice overexpressing p35 (and thus having elevated Cdk5 activity) are more sensitive to thermal pain.

Research Summary

This study demonstrates the role of Cdk5 in nociceptive signaling. It identifies the expression of Cdk5 and its activator p35 in nociceptive neurons and shows that this expression is modulated during peripheral inflammation. Inflammation leads to increased calpain activity, which in turn cleaves p35 to p25, resulting in elevated Cdk5 activity. Genetically modified mice with altered Cdk5 activity levels show corresponding changes in their sensitivity to painful thermal stimuli. The findings suggest that Cdk5-p35 activity plays a significant role in primary afferent nociceptive signaling and could be a potential target for analgesic drug development.

Practical Implications

Analgesic Drug Target

Cdk5-p35 may be a potential target for the development of analgesic drugs.

Understanding Chronic Pain

The study provides insights into the molecular mechanisms underlying pain hypersensitivity and chronic pain conditions.

Therapeutic Interventions

Modulating Cdk5 activity could be a therapeutic strategy for managing pain.

Study Limitations

1
The study focuses on thermal pain; other types of pain may involve different mechanisms.
2
The findings are based on animal models; further research is needed to confirm these results in humans.
3
The precise downstream targets of Cdk5 in pain signaling remain to be fully elucidated.

Your Feedback

Was this summary helpful?

Back to Neurology